We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NVRO market cap is 307.42M. The company's latest EPS is USD -2.5107 and P/E is -3.33.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 96.33M | 108.81M | 103.86M | 116.18M | 101.9M |
Operating Income | -36.32M | -25.64M | -25.56M | -11.79M | -35.83M |
Net Income | -35.03M | -24.72M | -23.48M | -8.98M | -25.41M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 390.26M | 362.05M | 386.91M | 511.37M | 425.17M |
Operating Income | -96.48M | -62.85M | -110.93M | 6.16M | -99.31M |
Net Income | -103.69M | -83.07M | -131.36M | 3M | -92.21M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 574.42M | 569.52M | 561.58M | 635.71M | 596.05M |
Total Liabilities | 273.2M | 274.77M | 275.92M | 342.57M | 317.51M |
Total Equity | 301.23M | 294.75M | 285.67M | 293.15M | 278.54M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 469.65M | 789.43M | 574.54M | 602.41M | 635.71M |
Total Liabilities | 253.29M | 400.97M | 270.93M | 278.53M | 342.57M |
Total Equity | 216.35M | 388.46M | 303.62M | 323.88M | 293.15M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -29.31M | -43.82M | -49.91M | -58.83M | -32.66M |
Investing | -24.65M | -13.37M | -6.09M | -7.2M | 25.32M |
Financing | -2.27M | 1.85M | 836k | 49.53M | -6.48M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -50.23M | 1.19M | -41.88M | 24.68M | -58.83M |
Investing | 32.33M | -369.87M | 201.72M | 64.29M | -7.2M |
Financing | 32.09M | 346.91M | -169.38M | -2.46M | 49.53M |
Market Cap | 307.42M |
Price to Earnings Ratio | -3.33 |
Price to Sales Ratio | 0.72 |
Price to Cash Ratio | 2.95 |
Price to Book Ratio | 1.05 |
Dividend Yield | - |
Shares Outstanding | 36.73M |
Average Volume (1 week) | 278.73k |
Average Volume (1 Month) | 529.23k |
52 Week Change | -65.28% |
52 Week High | 25.71 |
52 Week Low | 7.85 |
Spread (Intraday) | 2.92 (29.44%) |
Company Name | Nevro Corp |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.nevro.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions